Literature DB >> 12607774

The expressions of intracellular cytokines in the lymphocytes of preeclamptic patients.

Dorota Darmochwal-Kolarz1, Jacek Rolinski, Bozena Leszczynska-Goarzelak, Jan Oleszczuk.   

Abstract

PURPOSE: The objective of the study was to investigate the intracellular expressions of T helper 1 (Th1) and Th2 cytokines in peripheral blood T lymhocytes and natural killer (NK) cells of patients with preeclampsia and women with uncomplicated pregnancy. METHOD OF STUDY: Blood samples were taken from 20 patients with preeclampsia and 16 healthy pregnant women. Mononuclear cells were isolated from peripheral blood and stimulated for 5 hr at 37 degrees C and 5% CO2. Next, the cells were stained with antibodies against surface markers of T-cell subsets and NK cells. After fixation and permeabilization processes, the cells were stained with antibodies against intracellular cytokines--interleukin-2 (Il-2) and interferon-gamma (IFN-gamma) as well as Il-10 and Il-4. The intracellular expressions of Th1 and Th2 cytokines were determined using the flow cytometric method. Statistical analysis was performed using Mann-Whitney U-test.
RESULTS: We found that in patients with preeclampsia the expressions of Il-2 were significantly higher when compared with women with uncomplicated pregnancy. Furthermore, in the group of patients with preeclampsia the expressions of Il-2 were higher in T CD 8+ lymphocytes than in T CD4+ cells. The expressions of IFN-gamma did not differ in CD4+ cells and CD8+ cells in both studied groups but they were higher in NK cells in the study group. The expressions of Il-10 were lower in lymphocytes of preeclamptic patients when compared with controls. The expressions of Il-4 did not differ in both studied groups.
CONCLUSIONS: These results suggest that in patients with preeclampsia there is Th1/Th2 imbalance, with predominant Th1 immunity.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12607774     DOI: 10.1034/j.1600-0897.2002.01089.x

Source DB:  PubMed          Journal:  Am J Reprod Immunol        ISSN: 1046-7408            Impact factor:   3.886


  20 in total

1.  Interleukin-17 signaling mediates cytolytic natural killer cell activation in response to placental ischemia.

Authors:  Olivia K Travis; Dakota White; Cedar Baik; Chelsea Giachelli; Willie Thompson; Cassandra Stubbs; Mallory Greer; James P Lemon; Jan Michael Williams; Denise C Cornelius
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2020-04-22       Impact factor: 3.619

2.  Regulation of monocyte chemoattractant protein-1 expression by tumor necrosis factor-alpha and interleukin-1beta in first trimester human decidual cells: implications for preeclampsia.

Authors:  Charles J Lockwood; Paul Matta; Graciela Krikun; Louise A Koopman; Rachel Masch; Paolo Toti; Felice Arcuri; Se-Te Joseph Huang; Edmund F Funai; Frederick Schatz
Journal:  Am J Pathol       Date:  2006-02       Impact factor: 4.307

Review 3.  Inflammatory mediators: a causal link to hypertension during preeclampsia.

Authors:  Denise C Cornelius; Jesse Cottrell; Lorena M Amaral; Babbette LaMarca
Journal:  Br J Pharmacol       Date:  2018-09-28       Impact factor: 8.739

4.  Maternal plasma fetuin-A concentration is lower in patients who subsequently developed preterm preeclampsia than in uncomplicated pregnancy: a longitudinal study.

Authors:  Piya Chaemsaithong; Roberto Romero; Adi L Tarca; Steven J Korzeniewski; Alyse G Schwartz; Jezid Miranda; Ahmed I Ahmed; Zhong Dong; Sonia S Hassan; Lami Yeo; Tinnakorn Tinnakorn
Journal:  J Matern Fetal Neonatal Med       Date:  2014-09-29

Review 5.  Physiological and molecular determinants of embryo implantation.

Authors:  Shuang Zhang; Haiyan Lin; Shuangbo Kong; Shumin Wang; Hongmei Wang; Haibin Wang; D Randall Armant
Journal:  Mol Aspects Med       Date:  2013-01-02

6.  Serum levels of neopterin and interleukin-2 receptor in women with severe preeclampsia.

Authors:  Ilknur Kaleli; Babur Kaleli; Melek Demir; Basak Yildirim; Nural Cevahir; Suleyman Demir
Journal:  J Clin Lab Anal       Date:  2005       Impact factor: 2.352

7.  Proportion of peripheral blood and decidual CD4(+) CD25(bright) regulatory T cells in pre-eclampsia.

Authors:  Y Sasaki; D Darmochwal-Kolarz; D Suzuki; M Sakai; M Ito; T Shima; A Shiozaki; J Rolinski; S Saito
Journal:  Clin Exp Immunol       Date:  2007-04-25       Impact factor: 4.330

8.  Maternal serum soluble CD30 is increased in normal pregnancy, but decreased in preeclampsia and small for gestational age pregnancies.

Authors:  Juan Pedro Kusanovic; Roberto Romero; Sonia S Hassan; Francesca Gotsch; Samuel Edwin; Tinnakorn Chaiworapongsa; Offer Erez; Pooja Mittal; Shali Mazaki-Tovi; Eleazar Soto; Nandor Gabor Than; Lara A Friel; Bo Hyun Yoon; Jimmy Espinoza
Journal:  J Matern Fetal Neonatal Med       Date:  2007-12

9.  Serum granulysin is a marker for Th1 type immunity in pre-eclampsia.

Authors:  M Sakai; K Ogawa; A Shiozaki; S Yoneda; Y Sasaki; K Nagata; S Saito
Journal:  Clin Exp Immunol       Date:  2004-04       Impact factor: 4.330

Review 10.  The Role of Interleukin-10 in the Pathophysiology of Preeclampsia.

Authors:  Hajrunisa Cubro; Sonu Kashyap; Meryl C Nath; Allan W Ackerman; Vesna D Garovic
Journal:  Curr Hypertens Rep       Date:  2018-04-30       Impact factor: 5.369

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.